Kancera
Pharmaceutical company seeking a reverse takeover to leverage its public listing.
KAN | ST
Overview
Corporate Details
- ISIN(s):
- SE0015658570 (+1 more)
- LEI:
- 5493002P3RCOFW6HI207
- Country:
- Sweden
- Address:
- Nanna Svartz väg 4, 171 65 SOLNA
- Website:
- https://kancera.com/en/
Description
Novakand Pharma AB, formerly Kancera AB, is a pharmaceutical company that was focused on the development of small molecule therapeutics. Its primary research areas included cancer and inflammatory diseases. The company's pipeline featured drug candidates targeting the fractalkine system for cardiovascular and inflammatory conditions, as well as ROR inhibitors for oncology applications such as leukemia and solid tumors. Following a strategic review prompted by challenging capital market conditions, the company has initiated a process to seek a reverse takeover, aiming to leverage its public listing and cash assets for a merger with another entity.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Kancera filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kancera
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kancera via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
